ACE2 and COVID-19: Accumulated evidence in this field shows that specific conditions are associated with ACE2 deficiency and dysregulation of the RAAS [45] (extremely advanced age [46], male gender [47], the presence of diabetes [48], lung derivation [49] and history of cardiovascular events [50]), with risk factors for an increased severity of what is reported in COVID-19 [20,21,22].